The Weekly Roundup for October 24, 2025: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Isn’t It Time for Stricter Valproic Acid Warnings for Women of Reproductive Age?
Despite FDA warnings, valproate is still prescribed to women of reproductive age, placing children at risk for birth defects and neurodevelopmental disorders.
The Weekly Roundup for October 10, 2025: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Beyond the FDA Panel: Medical Experts Reaffirm the Safety and Essential Role of SSRIs for Perinatal Mental Health
The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; however, medical organizations and experts support the important role of SSRIs and other medications in supporting maternal mental health.
Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring
Prenatal exposure to valproate is linked to increased risk of autism spectrum disorder, ADHD, lower IQ, and intellectual disability, especially at higher doses.
Behavioral Activation Reduces Suicidal Ideation in Women with Perinatal Depression
Behavioral activation significantly reduced suicidal ideation in women with perinatal depression, showing effectiveness whether delivered in-person or remotely by specialists and non-specialists.